SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%
News
IIN
--
0.00%
--
Stifel Maintains Buy on IntriCon, Lowers Price Target to $23
Stifel maintains IntriCon (NASDAQ:IIN) with a Buy and lowers the price target from $28 to $23.
Benzinga · 05/20 13:38
B. Riley FBR Maintains Buy on IntriCon, Raises Price Target to $28
B. Riley FBR maintains IntriCon (NASDAQ:IIN) with a Buy and raises the price target from $26.5 to $28.
Benzinga · 05/20 11:37
IntriCon Corporation (IIN) CEO Mark Gorder on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/20 03:33
IntriCon Q1 EPS $(0.220) May Not Compare To $(0.090) Estimate, Sales $21.500M Miss $23.280M Estimate
IntriCon (NASDAQ:IIN) reported quarterly losses of $(0.220) per share which missed the analyst consensus estimate of $(0.090) by 144.44 percent. This is a 375 percent decrease over earnings of $0.080 per share from the
Benzinga · 05/19 20:13
IntriCon Reports First Quarter 2020 Results
ARDEN HILLS, Minn., May 19, 2020 -- IntriCon Corporation (NASDAQ: IIN), a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical.
GlobeNewswire · 05/19 20:12
IntriCon takes out Emerald Medical Services in cash and stock deal
Seeking Alpha - Article · 05/19 20:10
IntriCon Reports Purchase Of Emerald Medical Services For $7.1M, 80K Shares Of Common Stock, Cash Earnout Based On Achievement Of Specific Sales Milestones
Benzinga · 05/19 20:03
IntriCon Acquires Emerald Medical Services
Synergistic joint development and manufacturing capability expands market opportunity in surgical navigationProvides immediate access to technology platform serving new high.
GlobeNewswire · 05/19 20:03
Intricon Corp. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / May 19, 2020 / Intricon Corp. (NASDAQ:IIN) will be discussing their earnings results in their 2020 First Quarter Earnings call to be held on May 19, 2020 at 5:00 PM Eastern ...
ACCESSWIRE · 05/19 19:00
IntriCon to Announce 2020 First-Quarter Results on Tuesday, May 19, 2020
ARDEN HILLS, Minn., May 11, 2020 -- IntriCon Corporation (NASDAQ: IIN), a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical.
GlobeNewswire · 05/11 20:05
IntreCon Announces That Sara Hill Was Appointed As Chief Human Resource Officer
Benzinga · 04/30 20:45
IntriCon Announces Appointment of Sara Hill as Chief Human Resource Officer
IntriCon Corporation (IIN), a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today announced Sara Hill has been appointed Chief Human Resource Officer. As a key member of IntriCon's executive leade
GlobeNewswire · 04/30 20:16
IntriCon pulls FY20 guidance
Seeking Alpha - Article · 04/07 21:32
B. Riley FBR Maintains Buy on IntriCon, Lowers Price Target to $26.5
B. Riley FBR maintains IntriCon (NASDAQ:IIN) with a Buy and lowers the price target from $29 to $26.5.
Benzinga · 04/07 12:40
IntriCon Corporation Announces Change to Virtual Meeting Format for its Annual Meeting of Shareholders to be Held on April 28, 2020
GlobeNewswire · 03/31 21:09
IntriCon Appoints Heather Rider to its Board of Directors
GlobeNewswire · 03/19 13:00
Did You Miss IntriCon's (NASDAQ:IIN) 82% Share Price Gain?
Simply Wall St. · 03/09 18:11
Edited Transcript of IIN earnings conference call or presentation 24-Feb-20 10:00pm GMT
Thomson Reuters StreetEvents · 03/03 19:50
B. Riley FBR Maintains Buy on IntriCon, Lowers Price Target to $29
B. Riley FBR analyst Andrew D'Silva maintains IntriCon (NASDAQ:IIN) with a Buy and lowers the price target from $34 to $29.
Benzinga · 02/25 13:04
IntriCon EPS beats by $0.14, beats on revenue
seekingalpha · 02/25 02:41